Pharmaceutical industry response to national war on cancer

The UK Government has launched an ambitious 10-Year Cancer Plan to make the country’s cancer care system the ‘best in Europe’.

In response Paul Catchpole, Director of Value and Access Policy, the ABPI said:

“Today’s announcement is a hugely positive sign that the UK Government will begin to address the long-term weaknesses in cancer care and the devastating impact that COVID-19 has had on NHS cancer services.

“Reducing the significant variations in cancer care across the UK and speeding up access to the most effective treatments for all NHS patients will be crucial. Increasing investment in medicines on a par with European and G7 nations and adopting the best practice of those nations that are leading the way in cancer diagnosis and treatment will also be fundamental to the success of the plan.

“With exciting new therapies coming through the pipeline – including advances in immunotherapies and gene therapies, as well as new medicines for rare disease – putting NHS patients to the front of the queue is a welcome ambition.”